Aryl Ether-Substituted Heterocyclic Compounds as GLP1R Agonists
Copyright © Targeted News Service 2026
2026-08-04
ALEXANDRIA, Virginia, Aug. 4 -- MINDRANK AI LTD., Hangzhou, China has been assigned a patent (No. US 12698270 B2, initially filed Jan. 31, 2022) developed by three inventors Long Zhang, Hangzhou, China; Zhangming Niu, Hangzhou, China; and Bowen Tang, Hangzhou, China, for "Aryl ether-substituted heterocyclic compounds as GLP1R agonists." . . .
